Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed()()()()

Documenti analoghi

• Suspicion of mitochondrial disease remains frequently unconfirmed after whole exome sequencing
  di: Finsterer, Josef, et al.
  Pubblicazione: (2018)
• Letter to the Editor: Endocrine Compromise in Mitochondrial Disorders
  di: Finsterer, Josef, et al.
  Pubblicazione: (2018)
• Treating mitochondrial disorders requires full exploitation of available therapeutic options
  di: Finsterer, Josef, et al.
  Pubblicazione: (2017)
• MicroRNAs are inappropriate for characterising hearing impairment in mitochondrial disorders
  di: Finsterer, Josef, et al.
  Pubblicazione: (2018)
• Mitochondrial multiorgan disorder syndrome (MIMODS) due to a compound heterozygous mutation in the ACAD9 gene()
  di: Finsterer, Josef, et al.
  Pubblicazione: (2017)